InnovaDerma (LSE: IDP), a UK developer of life sciences, beauty and personal care products, announces, it was notified on 26 February 2019 that Joseph Bayer, Executive Director/Finance Director has purchased 5,000 Ordinary Shares at a price of 86 pence per Ordinary Share (the "Purchase").
Following the Purchase, Joseph Bayer personally now holds a total of 28,180 shares. He also has a separate holding of 93,333 Ordinary Shares held via his Australian Superannuation Fund which Mr Bayer controls. Therefore, Joseph Bayer's total interest in the Company through direct and indirect holdings is 121,513 Ordinary Shares representing approximately 0.84% of the issued share capital of the Company.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
Details of the person discharging managerial responsibilities / person closely associated
Reason for the Notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the Financial instrument, type of instrument
€0.10 each ("Ordinary Shares")
Nature of the transaction
Purchase of Ordinary Shares
Price(s) and volume(s)
Volume and Price - 5,000 Ordinary Shares at 86 pence per share
See 4c) above
Date of the transaction
26 February 2019
Place of the transaction
London Stock Exchange, Main Market
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
InnovaDerma PLC (LON:IDP) executive chairman Haris Chaudhry and CEO Kieran Callan caught up with Proactive London's Andrew Scott to discuss their trading update for the 12 months to 30 June 2019.
The maker of beauty and personal care products said revenues had increased by 21% to...